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Abstract
The article examines the practice of cell therapies, often named as stem cell 
therapies. For the general public this is recognized as promising treatment for 
many diseases, offering hope for many people to restore health to themselves 
or their loved ones. However, despite the enormous potential that this type of 
treatment holds, it has its limitations. The tension between hope, science, truth 
and deception can come to the fore especially when someone is fighting for 
their life. Moral and ethical issues play a key role in such cases, serving as guide­
posts obscured, however, by information noise. 
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We live in a time when science is enjoying unprecedented success. Science 
has proven that its methodology is correct; it has the power to uncover 
truths about the world, and it has demonstrated that scientific knowledge 
can be used in practical situations. Thanks to science, we can travel around 
the world, flying in planes weighing hundreds of tons. Thanks to science, 
human beings were able to travel to the Moon and return safely back 
to Earth. Understanding biological mechanisms has allowed scientists to 
demonstrate that diseases have a natural origin, enabling scientists to de­
velop effective methods for their diagnosis and treatment. Science has not 
only allowed us to cure diseases, but also prevent some of them. Thanks to 
science, and the introduction of vaccines, antibiotics and improved living 
conditions, the rate of child mortality has dropped significantly. Although, 
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of course, things still need to improve in many regions of the world, one 
can see the significant progress that has been made in the last 50 years.
Humans can fly from continent to continent, and even into space. Hu­
mans can treat diseases by acting effectively against disrupted biological 
processes. This can only be done through science. No religion is effec­
tive. No prayers of billions of believers can move a heavy object from the 
ground; no miracle healing happens because of faith. 
However, in a time when everyone is dependent on science and its 
products, the truth of science is facing attacks from various sides. Paradox­
ically, despite still underestimating the significance and power of science, 
people expect miracles to happen, particularly in the field of biomedical 
science. People expect medicine to cure all diseases. However, concomi­
tantly, there is a common lack of knowledge and misunderstanding of bio­
logical processes. Despite the effectiveness of vaccines, the anti-vaccine 
movement is growing, dispersing fake news about their side effects, in­
cluding dubious claims that they cause autism. Europeans, in particular, 
are suspicious about the alleged dangers of plant genetic modification. 
Sociological pools demonstrate not-so-rare irrational beliefs that “natural” 
organisms do not contain genes, in contrast to genetically modified ones. 
Supporters of so-called natural products boost the enormous market of 
food supplements, claiming that they have miraculous effects on every 
real (as well as fake) health problem. 
People want to live longer, stay young longer, and they want a cure 
for every disease. People are looking for a miracle and are reluctant to ac­
cept the truth. This is because the truth can often be harsh. We still don’t 
have a cure for every disease; many treatments are ineffective, and even 
effective treatments can cause unpleasant and sometimes dangerous side-
effects. People desperately look for hope. This is their right, particularly for 
severely sick patients or the parents of sick children. They search the inter­
net and look for miracle treatments, and often find… hype.
As in other forms of social activity, it’s no different in science and medi­
cine. One can find many who claim to possess the answers to our problems, 
that they have miracles within arm’s reach. Like populist politicians who claim 
they have the answer to every social problem, like priests offering eternal 
salvation, there are populist scientists and physicians who claim they have 
a cure for almost every health problem. They have stem cells. Like populists 
who claim that everything is very easy to achieve, populist physicians and sci­
entists say that stem cells are the way to treat incurable diseases – particularly, 
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so-called adult stem cells which, they claim, can be isolated from tissues such 
as fat, or from the remnants of childbirth, namely the umbilical cord. Moreo­
ver, their application appears to be very easy and safe. However, I would like 
to give some examples of how this actually works.
Stem cells are cells which can self-renew, generating other stem cells 
by cell division, and which can differentiate into specialized cell types (Blau 
and Daley 2019). However, there is no one group of stem cells, and differ­
ent stem cells have different properties. There are cells which are totipo­
tent, which can create a whole organism, and these are zygotes or the first 
blastomeres being the result of a zygote’s cell division. There are pluripo­
tent cells, such as embryonic stem cells, which are derivatives of the in­
ner cell mass of an early embryo (blastocyst) and which can be cultured 
in the laboratory practically indefinitely. Although pluripotent cells can in­
deed differentiate into almost every cell type of the human body, except 
the trophoblast (which contributes to the placenta), they cannot create 
a whole organism. In our organs, as in bone marrow, we have multipotent 
stem cells which can differentiate into many cell types but only of one giv­
en group. While hematopoietic stem cells from the bone marrow can dif­
ferentiate into every blood cell type, they cannot form bone. On the other 
hand, in bone marrow there are skeletal stem cells (named mesenchymal 
stem cells) which can form chondrocytes, adipose cells and bone – but 
not blood cells. Finally, we have unipotent stem cells, such as, for exam­
ple, certain cells in the skin or the satellite cells in our muscles, which can 
differentiate into the cells of a given tissue: the epidermis or the skeletal 
muscles, respectively.
Stem cells are very effective and really powerful. From each zygote 
more than 200 different cell types can be created. A whole human body 
consists of more than 1012 cells. Hematopoietic stem cells (HSCs) in our 
bone marrow regenerate blood, giving rise to 200 billion red blood cells, 
10 billion white blood cells, and 400 billion platelets every day. HSCs can 
save lives because they can be used to treat blood disorders such as leuke­
mia, anemia or immune deficiencies. They can be harvested from the bone 
marrow or mobilized to the donor’s blood, collected and injected into 
the patient in need. These treatments are very efficient and have saved the 
lives of hundreds of thousands of people. Of course, as they still need re­
finement, scientists are still looking for ways to improve methods of HSC 
mobilization. For example, in our recent study we described new way of 
HSC mobilization to the blood of experimental mice (Szade et al. 2020). 
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Of course, before any application in human beings, such an approach has 
to be carefully tested in order to ensure it is safe and effective.
We have stem cells in different organs of our body. We have stem 
cells in certain parts of the brain, but not in every region of it. We have 
stem cells which regenerate our skin. We have stem cells which constantly 
repair the internal lining (epithelium) of our intestines. We have satellite 
cells which regenerate our muscles. We have stem cells in the bone mar­
row, regenerating our blood (HSCs) and skeletal stem cells, which can re­
generate our bones. When a child is born, some blood can be collected 
from the umbilical cord and this umbilical cord blood contains HSCs, as in 
bone marrow, and can be used for the treatment of blood diseases (but 
not in the same child!). Stem cells are thus used to regenerate the corneal 
epithelium of the eye, regenerate blood in hematopoietic diseases or re­
generate skin.
Recently, a combination of stem cell therapy with gene therapy has al­
lowed scientists to treat diseases that have until now been incurable, such 
as severe combined immunodeficiency syndromes (SCIDs) – when a child is 
born without an immune system and there is a danger of dying from infec­
tions that would normally not be harmful. One example of such a SCID is 
adenosine deaminase immunodeficiency (ADA). The Italian scientists and 
physicians have developed a method for its treatment, named Strimvelis, 
which since 2016 has been registered by the European Medicines Agency. 
Strimvelis combines gene and cell therapy. A sick child’s stem cells, which 
are not able to differentiate efficiently into various blood cells, are isolat­
ed from the patient’s bone marrow and modified in vitro with the correct 
ADA gene that is missing in the patient. Then these engineered stem cells 
are reinfused back into the patient in order to restore their immune sys­
tem. Strimvelis is really safe and effective for patients with ADA-SCID (De 
Luca et al. 2019) 
Skin stem cells can help regenerate our skin. However, they cannot al­
ways do it effectively; for example, when there is extensive skin damage 
due to severe burns. At the same time, in such a case skin stem cells can 
be isolated from the part of the skin that is not damaged; they can be mul­
tiplied in the laboratory and differentiated into epidermal keratinocytes 
which can then be applied to the damaged areas.
In 2015 the European Medicines Agency registered Holoclar, which is 
a method used to regenerate a damaged corneal epithelium using a pa­
tient’s own limbal stem cells. When the cornea is damaged, for example, 
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by chemicals, it can result in the loss of sight. However, if the limbal stem 
cells, namely the stem cells which normally regenerate the corneal epithe­
lium, are not fully destroyed, they can be taken from the eye, multiplied in 
the laboratory, and the obtained cornea epithelium can be injected back 
into the eye of the patient (De Luca et al. 2019). 
The potential of epidermal stem cells to regenerate damaged skin has 
been recently demonstrated in a joint effort of German physicians and Ital­
ian scientists who saved the life of a Syrian boy severely suffering from 
junctional epidermolysis bullosa (EB), a devastating terminal disease. As 
this boy does not have the correct laminin 332 gene, he lacks this protein 
that is required for the proper functioning of the skin. In EB, the skin of 
patients is severely damaged, as in this boy, who lost almost 60% of his 
total body protective surface. To save his life, which was threatened by 
repeated sepsis, the researchers took a piece of undamaged skin, isolated 
the stem cells, introduced the proper gene into these stem cells and multi­
plied and then differentiated them, generating skin epidermis, which they 
applied to the damaged body of the patient. In this way they saved the life 
of the boy who can now lead a normal life (De Luca et al. 2019). 
To summarize, stem cells from the bone marrow which contain HSCs 
can be used to treat blood diseases. Epidermal stem cells can be used to 
regenerate skin. Limbal stem cells in the eye can regenerate the corneal 
epithelium. However, some even claim that HSCs or so-called mesenchymal 
stem cells can be used to treat any organ imaginable, not only to regen­
erate the blood, but also to regenerate muscles, the skin, heart, liver and 
even the nervous system (for references see: Dulak et al. 2015, Langrzyk et 
al. 2018). Moreover, even at websites such as the American registry of clini­
cal trials2, one can find an enormous list of diseases which are claimed be 
treated with stem cells isolated from the bone marrow or other sources. 
Nevertheless, there is a lack of convincing evidence on the applica­
tion of one type of cell for the treatment of so many unrelated diseases. 
Although supporters state that there are numerous studies used to prove 
that these cells are effective, there are also serious concerns over the 
integrity of this research. 
But why does this happen? The simplest answer is that stem cells 
are considered as a cure-all. The supporters claim that stem cells can be 
2 See: https://clinicaltrials.gov/.
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isolated from bone marrow, fat, teeth, menstrual blood or Wharton jelly 
(the gelatinous substance within the umbilical cord which is discarded af­
ter delivery). There are many clinics which claim that cells isolated from 
such tissues can be used to treat almost anything. There is a growing prob­
lem of unregulated, so-called stem cell therapies, which has led to stem 
cell tourism. This not only includes the United States and Asian countries 
but is happening in Poland as well. A search online brings up a list of dif­
ferent commercial institutions offering treatments for a host of diseases. 
These clinics charge sometimes an enormous amount of money for such 
a “treatment”. Clinic websites list diseases such as cerebral palsy, autism, 
amyotrophic lateral sclerosis, muscular dystrophies or different forms of 
blindness. They claim they can be treated with cells of the same cell type, 
isolated from the umbilical cord or cord blood. These cells, coming from 
unrelated donors, are injected into patients’ blood, spinal cord or the eye 
in hopes of curing patients (Sipp et al. 2017, Srivastava 2019).
One cell type for every disease. A miraculous treatment for everything. 
Why is this dubious? Firstly, different diseases have different backgrounds 
and origins, and many are not linked to cell loss that would require cell re­
placement with stem cells. As diseases affect different organs, it warrants 
the question as to why cells are isolated from unrelated organs, with func­
tions that are not well known and not even proven to be stem cells, being 
used to treat these diseases. 
Reports on the effectiveness of such treatments are doubtful. They in­
clude so-called medical experiments that are often performed without sci­
entific and medical scrutiny. There is no control group, no placebo. There 
is a lack of careful monitoring of patients and objective testing to confirm 
these treatments are effective. There is a lack of independent assessments 
by professional reviewers. Results are not published in peer-reviewed jour­
nals, and if they are, the quality of these papers and journals are often 
poor. We have to be aware, that as in the traditional press, there are re­
spectable journals and there are tabloids and a lot in between. Moreover, 
the claims concerning the effectiveness of such commercial treatments are 
also based on personal, unverified patient statements.
The suggestions that the same cell can be used to treat everything 
sounds like the Holy Grail, a “natural” miracle treatment for every condi­
tion. Looking back, one can find that this was started when the potential 
of embryonic stem cells (ESC), which indeed can differentiate to many cell 
types, was recognized, and hope for the treatment of incurable diseases 
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began to grow. However, reluctance and ethical objections to using ESC, 
due to the fact that obtaining them requires destroying the embryo, di­
rected interest to adult stem cells, with the belief that they can do the 
same as ESC. Unfortunately, they cannot, a fact that has been convincingly 
demonstrated. Perpetuating the claims on the pluripotency or multipo­
tency of adult stem cells indicates also that there is insufficient knowledge 
and a lack of understanding of biological mechanisms, stem cell proper­
ties and their real potential. 
Stem cell treatment sounds like a simple solution for everything and 
everyone. This is like populism or religion. Populism or religions do not 
need evidence. Populism relies on emotions and beliefs; the same is true 
for religion. Strange as it may seem, apparently, the problem of populism 
can also be found in science and medicine. The chaplains of such beliefs 
have straight and simple messages. They recognize the needs of others, 
saying that people have the right to try them out, that stem cells have 
to be applied quickly and that there is no need for prolonged research. 
They are vocal in making accusations that the rules of registering new drug 
treatments are dictated by soulless regulatory agencies which prevent the 
introduction of promising treatments for desperate patients. 
Although this may sound surprising, this is the basis of the arguments 
often used by clinics which offer such unjustified therapies. Populism is re­
ciprocal: there are patients in need and there are those who can fulfill such 
a need. Physicians who offer these types of treatments, the brave and gen­
erous, are eager to fulfill the wishes of ordinary people. 
One can ask: where is the problem in this? If stem cells work in some 
cases, why shouldn’t they work in others? Why are we so afraid? Firstly, 
treatment has to be evidence-based. In modern medicine treatment can­
not be offered on the basis of just beliefs, with no support from rigorously 
performed preclinical and clinical research. We also should react because 
there are serious side effects that come with this type of cell therapy (Daley 
2017, Marks et al. 2017, Mummery et al. 2014). People have lost their sight 
after being injected with cells isolated from fat; some patients developed 
a tumor at the site of injection of unknown “stem cells,” and some patients 
have even lost their lives. It is also assumed that many people who make 
a decision to go ahead with unregistered therapies do not report side ef­
fects. Therefore, the International Society for Stem Cell Research (ISSCR), 
the largest professional organization of scientists working on stem cells, 
have warned about the dangers of unproven stem cell-based intervention 
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(ISSCR 2016). This was done in 2016 when the first guidelines on this issue 
were released. Moreover, this was repeated in June 2019 and May 2021 
as there are still problems with clinics that offer unjustified therapies. Re­
cently, in spring 2020, a serious warning was issued by the Committee of 
Advanced Therapies of the European Medicines Agency (EMA 2020) and 
from the European Academies’ Science Advisory Council (EASAC) (EASAC 
2020). 
At the same time, despite the pessimistic messages and warnings of 
the risks, there is reasonable optimism. Stem cells have great potential and 
can be used for therapies – however, they must use real, not fake “stem” 
cells. Moreover, their application should not be rushed at the expense of 
basic research and without at least a basic understanding of stem cell prop­
erties and the mechanism of their actions. The potential of stem cell ther­
apy is immense and its application extends beyond regenerative medicine. 
However, even with such promising approaches, the old medical principle, 
primum non nocere, should be considered first of all. 
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